FINWIRES · TerminalLIVE
FINWIRES

AbbVie Raises 2026 Outlook Following First-Quarter Beat on Immunology Growth

By

-- AbbVie (ABBV) raised its full-year outlook on Wednesday as the biopharmaceutical company recorded better-than-expected first-quarter results, driven by robust revenue growth from its Skyrizi and Rinvoq immunology drugs.

Per-share adjusted earnings are expected at $14.08 to $14.28 for 2026, up from prior guidance of $13.96 to $14.16. The guidance includes $0.41 in expenses related to acquired in-process research and development and milestone expenses in the first quarter. The current consensus on FactSet is for non-GAAP EPS of $14.12.

AbbVie now expects revenue of about $67.3 billion for the current year, an increase of $300 million, Chief Financial Officer Scott Reents said during an earnings call, according to a FactSet transcript. The Street is looking for $67.07 billion.

The company's shares rose 0.9% in Wednesday trading. The stock has dropped 13% this year.

For the March quarter, the company reported adjusted EPS of $2.65, up from $2.46 a year earlier and ahead of the Wall Street estimate of $2.59. Revenue climbed 12% to $15 billion, surpassing the estimate on FactSet for $14.72 billion.

"We are off to an excellent start in 2026, with first-quarter results exceeding our expectations," CEO Robert Michael said in a statement. "AbbVie's key growth drivers continue to deliver strong performance and support our enhanced full-year outlook."

Global sales from the immunology portfolio rose 16% to $7.29 billion. Gains of 31% for Skyrizi and 23% for Rinvoq helped counter a 39% drop for Humira. In the neuroscience segment, revenue jumped 26% to $2.89 billion, while oncology portfolio sales eased 0.2% to $1.63 billion.

Revenue in the aesthetics portfolio increased 7.6% to $1.19 billion.

AbbVie projects adjusted EPS of $3.74 to $3.78 in the current quarter on revenue of $16.7 billion, including a foreign-exchange gain of 0.6%, Reents said on the call. Analysts project non-GAAP EPS of $3.75 on sales of $16.8 billion.

Price: $199.39, Change: $+1.70, Percent Change: +0.86%

Related Articles

Mining & Metals

RBC Maintains First Quantum's Outperform Rating, C$45 Price Target

RBC Capital Markets maintained its outperform, speculative risk, rating on the shares of First Quantum Minerals (FM.TO)' and its C$45.00 price target following the company's first-quarter results.RBC expects a modest negative reaction to the results, given a headline miss on EBITDA and adjusted earnings per share.The company reported a first-quarter EBITDA of US$326 million, below RBC's forecast of US$461 million and the consensus estimate of US$448 million.Adjusted loss of US$0.18 per share also missed RBC's EPS forecast of US$0.01 per share and the consensus estimate of US$0.06 per share.First Quantum's financial results were impacted by US$144 million of losses on hedges and from lower sales due to timing and inventory replenishment.Price: $33.64, Change: $-0.65, Percent Change: -1.90%

$FM.TO
Commodities

Delek Logistics Reports Q1 Throughput Gains in Delaware Basin, Mixed Elsewhere

Delek Logistics (DKL) reported Wednesday Q1 throughput growth across key Permian Basin assets, with mixed volumes across segments compared with a year earlier.In the Delaware Basin, natural gas gathering and processing volumes averaged 63.9 million cubic feet per day in Q1, up from 59.9 MMcf/d a year earlier.Crude gathering rose to 129,451 barrels per day for the quarter ended Mar. 31, down from 122,226 b/d a year earlier.Midland Gathering System crude volumes fell to 218,203 b/d for the quarter, down from 246,090 b/d a year earlier, the company added.Delek reported Plains Connection volumes of 212,359 b/d for the quarter, up from 179,240 b/d a year earlier.Terminalling throughputs averaged 135,744 b/d, compared with 135,404 a year earlier, while West Texas marketing volumes rose to 11,771 b/d from 10,826 b/d a year earlier.Crude pipeline volumes, non-gathered, averaged 62,758 b/d in Q1, up from 61,888 b/d a year earlier, while refined products pipelines to Enterprise Systems fell to 44,658 b/d, from 56,010 b/d a year earlier.El Dorado Gathering System volumes declined to 9,220 b/d from 10,321 b/d a year earlier, while East Texas Crude Logistics System volumes rose slightly to 27,284 b/d from 26,918 b/d over the year.Delek Logistics completed drilling of its first acid gas injection well at the Libby Gas Complex during the quarter, advancing its sour gas processing and handling capabilities in the Delaware Basin.Price: $52.52, Change: $+1.66, Percent Change: +3.26%

$DKL
Asia Markets

DAX Index Declines as German Inflation Jumps

Local equities were closed lower on Wednesday, as the market weighed Germany's latest inflation figures against the anticipated US Federal Reserve interest rate decision due later in the day.Amid a busy day for economic and corporate updates, the blue-chip DAX index closed the session 0.27% in the red.Preliminary data from Destatis showed German annual inflation accelerated to 2.9% in April from the previous 2.7%, behind the market forecast of 3%. The core inflation rate, which excludes food and energy prices, declined to 2.3% from 2.5% a month ago."Turning to the ECB, German inflation data adds to the evidence of increasing stagflationary pressures ahead of tomorrow's policy meeting. As much as the rise in actual inflation and inflation expectations will fuel the rate hike debate, growing signs of adverse growth effects will make aggressive rate hikes less straightforward," ING noted.Meanwhile, the ifo Institute said that German companies are accelerating their headcount reductions in response to persistent global instability, noting the layoffs are affecting nearly every industry sector. The ifo Employment Barometer fell to 91.3 points in April 2026, down from 93.4 points a month ago, hitting the lowest level since May 2020.On the corporate side, adidas (ADS.F) soared to the top of the DAX, climbing 8.35%, after outperforming first-quarter expectations and sticking to its full-year targets. The German sportswear giant posted a 14% increase in currency-neutral revenue to 6.59 billion euros, surpassing the consensus of 9% growth, and expects a high-single-digit currency-neutral sales jump for 2026, corresponding to 2 billion euros in absolute terms."Overall, a good print with the only major question likely to be the relative weakness of footwear in the mix and how much of the beat came from World Cup products. In our view, this is a strong performance with adidas winning in a number of important categories. Trading on 15x the stock was not pricing in a FY upgrade at this stage and we see this as likely to be enough to see a positive reaction today," Deutsche Bank Research wrote.On the other hand, Mercedes-Benz Group (MBG.F) reported a 5% decline in first-quarter revenue to 31.60 billion euros, with a sharp sales slump in China eclipsing rising demand for electric vehicles and growth across US and European markets. The German automaker was down 0.56% at closing.

$^DAX$ADS.F$MBG.F